DICER1 and thyroid cancer, nonmedullary, 2: Similarly, DICER1—a multifunctional endonuclease involved in miRNA processing and chromatin remodeling that is screened for by the Thyroseq testing panel—was mutated in 15.5% of cases, a frequency consistent with previous reports ranging from 10% to 55% in FTC and 10% in atypical follicular adenomas [16,18,19,23,24].